scispace - formally typeset
P

Peter Blanken

Researcher at Addiction Research Center

Publications -  63
Citations -  2156

Peter Blanken is an academic researcher from Addiction Research Center. The author has contributed to research in topics: Randomized controlled trial & Heroin. The author has an hindex of 24, co-authored 60 publications receiving 1954 citations. Previous affiliations of Peter Blanken include Utrecht University & Erasmus University Rotterdam.

Papers
More filters
Journal ArticleDOI

Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials

TL;DR: In this paper, the authors conducted two open label randomised controlled trials to determine whether supervised medical prescription of heroin can successfully treat addicts who do not sufficiently benefit from methadone maintenance treatment.
Journal ArticleDOI

Attentional bias predicts heroin relapse following treatment.

TL;DR: Pre-treatment attentional bias predicted relapse at 3-month follow-up, even when controlling for self-reported cravings at the test session, and CET does not specifically reduce attentional biases after therapy.
Journal ArticleDOI

Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials.

TL;DR: In this article, a cost utility analysis of co-prescription of heroin compared with methadone maintenance treatment for chronic, treatment resistant heroin addicts was carried out in six cities in the Netherlands.
Journal ArticleDOI

Heroin-assisted Treatment (HAT) a Decade Later: A Brief Update on Science and Politics

TL;DR: It is suggested that there is a mounting onus on the realm of politics to translate the—largely positive— data from completed HAT science into corresponding policy and programming in order to expand effective treatment options for the high-risk population of illicit opioid users.
Journal ArticleDOI

Cue exposure therapy for the treatment of opiate addiction: results of a randomized controlled clinical trial.

TL;DR: This is the first randomized controlled trial showing that CET, compared to a non-specific psychotherapy, might increase dropout and relapse rates among abstinent heroin-dependent clients in a drug-free setting.